We investigated oral fluid testing (OFT) among men who have sex with men (MSM) to increase HIV testing in Bali, Indonesia.
Click here to access the article.
Method
We distributed OFT in January–December 2018 to 813 MSM in Bali. Supervised testing was offered first, and unsupervised was only offered to an individual who declined supervised testing. Included participants were MSM, who did not have a HIV test result in the last 6 months and declined referral to facility-based testing. Of 813 participants, 93% (765/813) chose supervised testing and 7% (57/813) unsupervised.
Result
The OFT result was reactive for 83 (10%). Of whom 52/83 (63%) underwent confirmatory testing with 47/52 (90%) found HIV positive.
Among confirmed positives, 43/47 (92%) were enrolled in HATI study cohort, of whom 39 (91%) started treatment. At six months follow up, 25/39 (64%) of those initiating treatment were still receiving it. Furthermore, all of them had a suppressed viral load.
There was an increase in the mean number of MSM tested for HIV by HATI study Bali sites per month. The data shows from 100 (95%CI: 85–112) before the intervention to 152 (95% CI: 130–172) during the intervention.
Findings
Our findings show the potential utility of offering HIV oral fluid self-test kits to scale-up HIV testing in MSM. Trial registration: ClinicalTrials.gov identifier: NCT03429842.
